Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Therapy insight: priapism associated with hematologic dyscrasias

Abstract

Priapism is defined as a genuine erectile disorder, in which erection persists uncontrollably without sexual purpose. This disorder is often overlooked in comparison to other male sexual dysfunctions, principally because of its seeming rarity. Priapism, however, occurs frequently in certain patient populations, including those with hematologic dyscrasias. Most commonly, priapism affects patients with sickle cell disease. The reported prevalence rate in this group ranges between 29% and 42% of males. The significance of priapism is further emphasized by the fact that this disorder commonly causes erectile tissue damage and leads to the loss of functional erections. These observations highlight the need for proper clinical recognition of priapism in order to enable appropriate management. Here, the current knowledge of priapism as it relates to hematologic and coagulative diseases is discussed, with a focus on the diagnosis and treatment of the disorder.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Treatment algorithm for priapism.
Figure 2: Surgical shunts for the treatment of priapism.

Similar content being viewed by others

References

  1. Berger R et al. (2001) Report of the American Foundation for Urologic Disease (AFUD) thought leader panel for evaluation and treatment of priapism. Int J Impot Res 13 (Suppl 5): S39–S43

    PubMed  Google Scholar 

  2. Montague DK et al. (2003) American Urological Association guideline on the management of priapism. J Urol 170: 1318–1324

    Article  Google Scholar 

  3. Emond AM et al. (1980) Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 140: 1434–1437

    Article  CAS  Google Scholar 

  4. Fowler JE Jr et al. (1991) Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae. J Urol 145: 65–68

    Article  Google Scholar 

  5. Mantadakis E et al. (1999) Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol 21: 518–522

    Article  CAS  Google Scholar 

  6. Adeyoju AB et al. (2002) Priapism in sickle-cell disease; incidence, risk factors and complications— an international multicentre study. BJU Int 90: 898–902

    Article  CAS  Google Scholar 

  7. Nelson JH and Winter CC (1977) Priapism: evolution of management in 48 patients in a 22-year series. J Urol 117: 455–458

    Article  Google Scholar 

  8. Miller ST et al. (1995) Priapism in children with sickle cell disease. J Urol 154: 844–847

    Article  CAS  Google Scholar 

  9. Thuret I et al. (1996) Priapism following splenectomy in an unstable hemoglobin: hemoglobin Olmsted β141 (H19) Leu→Arg. Am J Hematol 51: 133–136

    Article  CAS  Google Scholar 

  10. Quigley M and Fawcett DP (1999) Thrombophilia and priapism. BJU Int 83: 155

    Article  CAS  Google Scholar 

  11. Schreibman SM et al. (1974) Management of priapism in patients with chronic granulocytic leukemia. J Urol 111: 786–788

    Article  CAS  Google Scholar 

  12. Steinhardt GF and Steinhardt E (1981) Priapism in children with leukemia. Urology 18: 604–606

    Article  CAS  Google Scholar 

  13. Morano SG et al. (2000) Treatment of long-lasting priapism in chronic myeloid leukemia at onset. Ann Hematol 79: 644–645

    Article  CAS  Google Scholar 

  14. Atala A et al. (1992) Priapism associated with asplenic state. Urology 40: 371–373

    Article  CAS  Google Scholar 

  15. Brown JA and Nehra A (1998) Erythropoietin-induced recurrent veno-occlusive priapism associated and end-stage renal disease. Urology 52: 328–330

    Article  CAS  Google Scholar 

  16. Fassbinder W et al. (1976) Factors predisposing to priapism in haemodialysis patients. Proc Eur Dial Transplant Assoc 12: 380–386

    CAS  PubMed  Google Scholar 

  17. Routledge PA et al. (1998) Case studies in therapeutics: warfarin resistance and inefficacy in a man with recurrent thromboembolism, and anticoagulant-associated priapism. Br J Clin Pharmacol 46: 343–346

    Article  CAS  Google Scholar 

  18. Bschleipfer TH et al. (2001) Heparin-induced priapism. Int J Impot Res 13: 357–359

    Article  CAS  Google Scholar 

  19. Klein LA et al. (1972) Surgical treatment of priapism: with a note on heparin-induced priapism. J Urol 108: 104–106

    Article  CAS  Google Scholar 

  20. Hebuterne X et al. (1992) Priapism in a patient treated with total parenteral nutrition. JPEN J Parenter Enteral Nutr 16: 171–174

    Article  CAS  Google Scholar 

  21. Foda MM et al. (1996) High-flow priapism associated with Fabry's disease in a child: a case report and review of the literature. Urology 48: 949–952

    Article  CAS  Google Scholar 

  22. Hinman F Jr (1960) Priapism; reasons for failure of therapy. J Urol 83: 420–428

    Article  Google Scholar 

  23. Pryor J et al. (2004) Priapism, peyronie's disease, penile reconstructive surgery. In Sexual Medicine Sexual Dysfunctions in Men and Women, 383–408 (Eds Lue TF et al.) Paris: Health Publications

    Google Scholar 

  24. Serjeant GR et al. (1985) Stilboestrol and stuttering priapism in homozygous sickle-cell disease. Lancet 2: 1274–1276

    Article  CAS  Google Scholar 

  25. Tarry WF et al. (1987) Urological complications of sickle cell disease in a pediatric population. J Urol 138: 592–594

    Article  CAS  Google Scholar 

  26. Datta NS (1977) Megalophallus in sickle cell disease. J Urol 117: 672–673

    Article  CAS  Google Scholar 

  27. Ramos CE et al. (1995) High flow priapism associated with sickle cell disease. J Urol 153: 1619–1621

    Article  CAS  Google Scholar 

  28. Lue TF et al. (1986) Priapism: a refined approach to diagnosis and treatment. J Urol 136: 104–108

    Article  CAS  Google Scholar 

  29. Hakim LS et al. (1996) Evolving concepts in the diagnosis and treatment of arterial high flow priapism. J Urol 155: 541–548

    Article  CAS  Google Scholar 

  30. Seftel AD et al. (1998) High flow priapism complicating veno-occlusive priapism: pathophysiology of recurrent idiopathic priapism? J Urol 159: 1300–1301

    Article  CAS  Google Scholar 

  31. Pond HS (1969) Priapism as the presenting complaint of myelogenous leukemia: case report and review of the physiology of erection and the pathophysiology and treatment of priapism. South Med J 62: 465–467

    Article  CAS  Google Scholar 

  32. Larocque MA and Cosgrove MD (1974) Priapism: a review of 46 cases. J Urol 112: 770–773

    Article  CAS  Google Scholar 

  33. Winter CC and McDowell G (1988) Experience with 105 patients with priapism: update review of all aspects. J Urol 140: 980–983

    Article  CAS  Google Scholar 

  34. Pohl J et al. (1986) Priapism: a three-phase concept of management according to aetiology and prognosis. Br J Urol 58: 113–118

    Article  CAS  Google Scholar 

  35. Levine JF et al. (1991) Recurrent prolonged erections and priapism as a sequela of priapism: pathophysiology and management. J Urol 145: 764–767

    Article  CAS  Google Scholar 

  36. Hinman F (1914) Priapism. Ann Surg 60: 689–716

    Article  CAS  Google Scholar 

  37. Melman A and Serels S (2000) Priapism. Int J Impot Res 12 (Suppl 4): S133–S139

    Article  Google Scholar 

  38. Burnett AL (2003) Priapism pathophysiology: clues to prevention. Int J Impot Res 15 (Suppl 5): S80–S85

    Article  Google Scholar 

  39. Lin G et al. (2003) Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol 170 (Suppl): S15–S19

    PubMed  Google Scholar 

  40. Champion HC et al. (2005) Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci USA 102: 1661–1666

    Article  CAS  Google Scholar 

  41. Feldstein VA (1993) Posttraumatic “high flow” priapism: evaluation with color flow doppler sonography. J Ultrasound Med 12: 589–593

    Article  CAS  Google Scholar 

  42. Chung SY et al. (2003) Novel technique in the management of low flow priapism. J Urol 170: 1952

    Article  Google Scholar 

  43. Mantadakis E et al. (2000) Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood 95: 78–82

    CAS  PubMed  Google Scholar 

  44. Monga M et al. (1996) Priapism in sickle cell disease: the case for early implantation of the penile prosthesis. Eur Urol 30: 54–59

    Article  CAS  Google Scholar 

  45. Rees RW et al. (2002) The management of low-flow priapism with the immediate insertion of a penile prosthesis. BJU Int 90: 893–897

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arthur L Burnett.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burnett, A. Therapy insight: priapism associated with hematologic dyscrasias. Nat Rev Urol 2, 449–456 (2005). https://doi.org/10.1038/ncpuro0277

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0277

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing